MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression.
Yaojie FuBryan MackowiakDechun FengHongkun LuYukun GuanTaylor LehnerHongna PanXin Wei WangYong HeBin GaoPublished in: Gut (2023)
The miR-223 plays a critical role in modulating hypoxia-induced tumour immunosuppression and angiogenesis, which may serve as a novel therapeutic target for HCC.